Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Prostate Cancer and Prostatic Diseases|December 24, 2002
Ultrasound-guided seminal vesicle biopsies in prostate cancerL F A Wymenga, F J Duisterwinkel, K Groenier, et al.
European Journal of Biochemistry|June 1, 1981
A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycinF J Duisterwinkel, J M De Graaf, P J Schretlen, et al.
The EMBO Journal|January 1, 1982
The elongation factor Tu.kirromycin complex has two binding sites for tRNA moleculesJ M van Noort, F J Duisterwinkel, J Jonák, et al.
Progress in Clinical and Biological Research|January 1, 1981
Genes VI, VII and IX of bacteriophage M13: identification of their products as minor capsid proteinsG F Simons, J Beintema, F J Duisterwinkel, et al.
Pharmaceutisch Weekblad. Scientific Edition|February 21, 1986
Bioavailability of orally administered zinc, using TaurizineF J Duisterwinkel, B G Wolthers, B J Koopman, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2000
Clinical implications of free-to-total immunoreactive prostate-specific antigen ratiosL F Wymenga, F J Duisterwinkel, K Groenier, et al.
European Journal of Biochemistry|June 1, 1981
Molecular properties of two mutant species of the elongation factor TuP H Van der Meide, F J Duisterwinkel, J M De Graaf, et al.
The EMBO Journal|January 1, 1984
Specific alterations of the EF-Tu polypeptide chain considered in the light of its three-dimensional structureF J Duisterwinkel, B Kraal, J M De Graaf, et al.
Pageof 1